Skip to main content
Fig. 2 | Trials

Fig. 2

From: Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events

Fig. 2

Reported adverse events (AEs) and adverse event selection criteria. a Gabapentin. Six clinical study reports (CSRs) we identified appeared to report all AEs. All other sources in this figure are public sources. b Quetiapine. Two CSRs we identified appeared to report all AEs. Two CSR-synopses reported AE results and AE selection criteria. All other sources in this figure are public sources

Back to article page

Trials

ISSN: 1745-6215